WeChat
Weibo
Channel
Company News
Company News 2026-01-10
Trust as the Breakthrough: FIMAN’s Resilient Growth
The "7th Global Medical Aesthetics Frontier Industry Conference & Annual Amazing Pioneer Medical Aesthetics Star Fashion Awards Ceremony" has successfully concluded in Shanghai. Leveraging its profound accumulation and continuous innovation in the field of active collagen, FIMAN won two prestigious awards in one fell swoop: FILLDERM won the "Outstanding Collagen Brand Award," and BIOYONCE won the "Collagen Product Breakthrough Innovation Award."
During the special "Roundtable Dialogue: Medical Aesthetics Pioneers—Exploring 2026" session, Ms. Zhao Qing, Vice General Manager of FIMAN, was invited to attend. She engaged in deep discussions with industry peers, sharing her unique insights on the future development trends of collagen and her profound reflections on building a healthy, sustainable medical aesthetics industry ecosystem, drawing upon her keen industry insight and forward-looking vision.
▌ The First and Second Half of Medical Aesthetics: Breaking Through with Trust and Ecosystem
The pursuit of beauty is an eternal theme for humanity, which is why the medical aesthetics industry is always full of vitality and continuously moving forward. Collagen is precisely the "gift of the Creator" endowed by evolution. With its natural existence in the human body and excellent biocompatibility, it possesses irreplaceable advantages in long-term safety. The development of collagen is advancing towards higher efficiency and greater inclusivity.
Ms. Zhao Qing stated that the collagen industry has reached an important watershed between the "first and second half":
The first half focused on the popularization of category awareness and the maturation of supply. Competition intensified during this phase while simultaneously cultivating the market;
The second half is about the contest of trust and ecosystem, which is mainly reflected in three levels:
1、Standardized production infrastructure configuration: This is the "admission ticket" to guarantee product supply;
2、Brand moat: The professional value, differentiated advantages, craftsmanship & quality, and consumer trust constitute the four factors that determine success or failure;
3、Ecological enterprise: Becoming a healthier and more ecological enterprise, allowing products and solutions to cover broader dimensions, and enabling the linkage of upstream and downstream sectors to co-build a better ecosystem.
For the entire collagen industry, trust is a scarce asset and the ultimate barrier. The final delivered quality determines the consumer's willingness to repurchase. This trust is not built in a day. To this end, FIMAN has always upheld long-termism, cultivating deeply in every link with solid actions. For FIMAN, 2025 is a year of accumulating strength and presenting a fruitful answer sheet. In this year, FIMAN turned the blueprint into reality by establishing the first industry medical bovine industrial base meeting EU standards, and the FIMAN Collagen Smart Factory also passed ISO 13485 quality system certification... From raw materials to terminal products, it effectively eliminates consumers' "quality anxiety" with transparent and reliable full-link quality control.
▌ 2026: Resilient Upward Growth, Reckless Blooming
FIMAN's 2026 will continue to take root downward—developing towards an "ecological enterprise." On one hand, FIMAN invests 10% of its revenue in R&D annually, persisting in basic research and innovative application exploration in the collagen field. Currently, FIMAN has established deep R&D cooperation with Shaanxi University of Science and Technology, Sichuan University, the National Institutes for Food and Drug Control (NIFDC), and others. It is also preparing a joint laboratory with Fudan University, laying out more scenarios to provide integrated solutions for "Medical Aesthetics + Medical + Health," continuously promoting the development of health and beauty undertakings. On the other hand, FIMAN is deepening its strategic cooperation with its brother group, Lanshen Pharmaceutical, continuing to expand the ecosystem in multiple fields such as biosynthetic medical devices, functional foods, and functional skincare products.
The market is impetuous, but FIMAN remains steadfast. In this era, focus is a luxury, and slowing down is a form of courage. In this fast-paced era, FIMAN defines the next future of the collagen industry with a "slow" yet "deep" long-distance run. "Every flower has its own growth rhythm; as long as we move forward with vigorous vitality and resilience, we will eventually transcend the hustle and bustle and bloom with abandon," said Ms. Zhao Qing.
During the special "Roundtable Dialogue: Medical Aesthetics Pioneers—Exploring 2026" session, Ms. Zhao Qing, Vice General Manager of FIMAN, was invited to attend. She engaged in deep discussions with industry peers, sharing her unique insights on the future development trends of collagen and her profound reflections on building a healthy, sustainable medical aesthetics industry ecosystem, drawing upon her keen industry insight and forward-looking vision.
The pursuit of beauty is an eternal theme for humanity, which is why the medical aesthetics industry is always full of vitality and continuously moving forward. Collagen is precisely the "gift of the Creator" endowed by evolution. With its natural existence in the human body and excellent biocompatibility, it possesses irreplaceable advantages in long-term safety. The development of collagen is advancing towards higher efficiency and greater inclusivity.
Ms. Zhao Qing stated that the collagen industry has reached an important watershed between the "first and second half":
The first half focused on the popularization of category awareness and the maturation of supply. Competition intensified during this phase while simultaneously cultivating the market;
The second half is about the contest of trust and ecosystem, which is mainly reflected in three levels:
1、Standardized production infrastructure configuration: This is the "admission ticket" to guarantee product supply;
2、Brand moat: The professional value, differentiated advantages, craftsmanship & quality, and consumer trust constitute the four factors that determine success or failure;
3、Ecological enterprise: Becoming a healthier and more ecological enterprise, allowing products and solutions to cover broader dimensions, and enabling the linkage of upstream and downstream sectors to co-build a better ecosystem.
For the entire collagen industry, trust is a scarce asset and the ultimate barrier. The final delivered quality determines the consumer's willingness to repurchase. This trust is not built in a day. To this end, FIMAN has always upheld long-termism, cultivating deeply in every link with solid actions. For FIMAN, 2025 is a year of accumulating strength and presenting a fruitful answer sheet. In this year, FIMAN turned the blueprint into reality by establishing the first industry medical bovine industrial base meeting EU standards, and the FIMAN Collagen Smart Factory also passed ISO 13485 quality system certification... From raw materials to terminal products, it effectively eliminates consumers' "quality anxiety" with transparent and reliable full-link quality control.
FIMAN's 2026 will continue to take root downward—developing towards an "ecological enterprise." On one hand, FIMAN invests 10% of its revenue in R&D annually, persisting in basic research and innovative application exploration in the collagen field. Currently, FIMAN has established deep R&D cooperation with Shaanxi University of Science and Technology, Sichuan University, the National Institutes for Food and Drug Control (NIFDC), and others. It is also preparing a joint laboratory with Fudan University, laying out more scenarios to provide integrated solutions for "Medical Aesthetics + Medical + Health," continuously promoting the development of health and beauty undertakings. On the other hand, FIMAN is deepening its strategic cooperation with its brother group, Lanshen Pharmaceutical, continuing to expand the ecosystem in multiple fields such as biosynthetic medical devices, functional foods, and functional skincare products.
The market is impetuous, but FIMAN remains steadfast. In this era, focus is a luxury, and slowing down is a form of courage. In this fast-paced era, FIMAN defines the next future of the collagen industry with a "slow" yet "deep" long-distance run. "Every flower has its own growth rhythm; as long as we move forward with vigorous vitality and resilience, we will eventually transcend the hustle and bustle and bloom with abandon," said Ms. Zhao Qing.